We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$6.24M
Cap. Flow
-$8.36M
Cap. Flow %
-0.43%
Top 10 Hldgs %
18.4%
Holding
264
New
14
Increased
88
Reduced
101
Closed
15

Top Buys

1
BPMC
Blueprint Medicines
BPMC
+$20.5M
2
CELH icon
Celsius Holdings
CELH
+$20M
3
AHCO icon
AdaptHealth
AHCO
+$19.3M
4
NOG icon
Northern Oil and Gas
NOG
+$18.9M
5
PRVA icon
Privia Health
PRVA
+$16.5M

Top Sells

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$24.9M
2
AVNT icon
Avient
AVNT
+$21.7M
3
ONTO icon
Onto Innovation
ONTO
+$20M
4
ALKS icon
Alkermes
ALKS
+$19.3M
5
VC icon
Visteon
VC
+$15.9M

Sector Composition

1 Healthcare 30.67%
2 Industrials 16.05%
3 Consumer Discretionary 13.81%
4 Technology 13.49%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLS icon
1
Chart Industries
GTLS
$49.3M 2.54%
267,354
-84,484
-24% -$15.7M
PLMR icon
2
Palomar
PLMR
$3.59B
$41.8M 2.16%
499,488
+3,102
+0.6% +$228K
SMPL icon
3
Simply Good Foods
SMPL
$980M
$36.9M 1.9%
1,152,330
-59,690
-5% -$1.96M
MTSI icon
4
MACOM Technology Solutions
MTSI
$20.4B
$35.8M 1.85%
691,556
-39,497
-5% -$2.16M
EVRI
5
DELISTED
Everi Holdings
EVRI
$33.2M 1.71%
2,048,434
+117,094
+6% +$2.16M
SMCI icon
6
Super Micro Computer
SMCI
$15.6B
$33M 1.7%
5,999,630
-1,008,950
-14% -$5.75M
CHDN icon
7
Churchill Downs
CHDN
$5.85B
$32.8M 1.69%
355,956
-1,812
-0.5% -$185K
NVEE
8
DELISTED
NV5 Global
NVEE
$32.1M 1.66%
1,037,020
+6,592
+0.6% +$215K
PPBI
9
DELISTED
Pacific Premier Bancorp
PPBI
$31.8M 1.64%
1,026,776
-439
-0% -$14.3K
MMSI icon
10
Merit Medical Systems
MMSI
$4.41B
$30.1M 1.55%
532,314
+7,106
+1% +$409K
BWIN
11
Baldwin Insurance Group
BWIN
$2.66B
$29.9M 1.54%
1,136,554
+894
+0.1% +$25.5K
TNET icon
12
TriNet
TNET
$2.74B
$27.7M 1.43%
388,994
-43
-0% -$3.5K
KRTX
13
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$27M 1.39%
119,828
-700
-0.6% -$142K
WHD icon
14
Cactus
WHD
$3.78B
$26.8M 1.38%
697,500
+222,895
+47% +$8.93M
FRPT icon
15
Freshpet
FRPT
$2.78B
$26.4M 1.36%
527,670
+42,809
+9% +$2.02M
PRFT
16
DELISTED
Perficient Inc
PRFT
$26.3M 1.36%
404,979
+25,370
+7% +$2.12M
PCRX icon
17
Pacira BioSciences
PCRX
$1.01B
$26.3M 1.36%
494,296
+155,076
+46% +$8.62M
LNTH icon
18
Lantheus
LNTH
$7B
$26.2M 1.35%
372,708
+26,219
+8% +$1.99M
EYE icon
19
National Vision
EYE
$1.66B
$25.6M 1.32%
785,394
+201
+0% +$6.53K
VRNS icon
20
Varonis Systems
VRNS
$5.46B
$25.6M 1.32%
966,312
-8,988
-0.9% -$256K
MODN
21
DELISTED
MODEL N, INC.
MODN
$24.7M 1.28%
722,762
+271
+0% +$7.83K
TMCI icon
22
Treace Medical Concepts
TMCI
$279M
$24.7M 1.28%
1,120,765
+51,881
+5% +$1M
FOUR icon
23
Shift4
FOUR
$3.99B
$24.6M 1.27%
550,645
+98,735
+22% +$4.15M
PLNT icon
24
Planet Fitness
PLNT
$4.14B
$24M 1.24%
415,681
+3,446
+0.8% +$248K
HAE icon
25
Haemonetics
HAE
$3.54B
$23.8M 1.23%
321,271
+89
+0% +$6.39K
1
2 3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Advisers held 264 positions worth $1.94B, down 0.32% from $1.94B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2022 filing shows 14 new, 88 increased, 101 reduced and 15 closed positions. Its largest new stake was Blueprint Medicines: 318,574 shares worth $21M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $24.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2022 buy was Blueprint Medicines: 318,574 shares worth $21M.
  • Emerald Advisers added most to AdaptHealth in Q3 2022, an estimated $19.3M increase.
  • Emerald Advisers's biggest Q3 2022 reduction was Avient, cutting an estimated $21.7M.
  • Emerald Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $24.9M.
  • Emerald Advisers's ten largest holdings make up 18% of its $1.94B portfolio in Q3 2022.
  • Emerald Advisers opened 14 new positions and closed 15 in Q3 2022.
  • Emerald Advisers's portfolio value fell 0.32% quarter-over-quarter to $1.94B.

Based on Emerald Advisers's 13F filing for Q3 2022, filed 25 Oct 2022.